Ainuovirine is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) that is used for the treatment of HIV-1 infection. This medication works by non-competitively binding to the viral… Read more
Ainuovirine is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) that is used for the treatment of HIV-1 infection. This medication works by non-competitively binding to the viral reverse transcriptase enzyme, effectively inhibiting the reverse transcription process required for viral replication. This category contains essential reference standards, including impurities, metabolites, and stable isotope-labelled versions, which are critical for comprehensive pharmaceutical analysis. Laboratories utilize these high-quality materials to support impurity profiling, conduct method validation, and ensure rigorous quality control throughout drug development and manufacturing processes. By employing these precise standards, researchers can accurately identify, quantify, and monitor the chemical profile of the parent compound, ensuring the efficacy and safety of the final pharmaceutical product in compliance with regulatory standards.